Review article · 2023 · Open access

Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma

Xiaoyan Yang, Yuan‐Fei Lu, Jianxia Xu, Yongzhong Du, Ri‐Sheng Yu

Molecules, 28(3), 1506 · Published 3 February 2023 · DOI 10.3390/molecules28031506

Open PDFView at the publisherCite this paper

In brief

“Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma” is a 2023 review article by Xiaoyan Yang and 4 co-authors, published in Molecules. OpenAlex counts 14 citations as of 21 November 2026, which puts it in the top 8% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Molecules.

Citations
14
Most cited in
2024 (4)
Field-weighted impact
0.21
References
181
Authors
5

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with an extremely poor prognosis and low survival rate. Due to its inconspicuous symptoms, PDAC is difficult to diagnose early. Most patients are diagnosed in the middle and late stages, losing the opportunity for surgery. Chemotherapy is the main treatment in clinical practice and improves the survival of patients to some extent. However, the improved prognosis is associated with higher side effects, and the overall prognosis is far from satisfactory. In addition to resistance to chemotherapy, PDAC is significantly resistant to targeted therapy and immunotherapy. The failure of multiple treatment modalities indicates great dilemmas in treating PDAC, including high molecular heterogeneity, high drug resistance, an immunosuppressive microenvironment, and a dense matrix. Nanomedicine shows great potential to overcome the therapeutic barriers of PDAC. Through the careful design and rational modification of nanomaterials, multifunctional intelligent nanosystems can be obtained. These nanosystems can adapt to the environment's needs and compensate for conventional treatments' shortcomings. This review is focused on recent advances in the use of well-designed nanosystems in different therapeutic modalities to overcome the PDAC treatment dilemma, including a variety of novel therapeutic modalities. Finally, these nanosystems' bottlenecks in treating PDAC and the prospect of future clinical translation are briefly discussed.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yang, X., Lu, Y., Xu, J., Du, Y., & Yu, R. (2023). Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. Molecules, 28(3), 1506. https://doi.org/10.3390/molecules28031506

MLA 9

Yang, Xiaoyan, et al. “Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.” Molecules, vol. 28, no. 3, 2023, p. 1506. https://doi.org/10.3390/molecules28031506.

Chicago

Yang, Xiaoyan, Yuan‐Fei Lu, Jianxia Xu, Yongzhong Du, and Ri‐Sheng Yu. 2023. “Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.” Molecules 28 (3): 1506. https://doi.org/10.3390/molecules28031506.

Harvard

Yang, X. et al. (2023) ‘Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma’, Molecules, 28(3), p. 1506. doi:10.3390/molecules28031506.

IEEE

X. Yang, Y. Lu, J. Xu, Y. Du, and R. Yu, “Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma,” Molecules, vol. 28, no. 3, p. 1506, 2023, doi: 10.3390/molecules28031506.

BibTeX

@article{yang2023recent,
  title     = {{Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma}},
  author    = {Yang, Xiaoyan and Lu, Yuan‐Fei and Xu, Jianxia and Du, Yongzhong and Yu, Ri‐Sheng},
  journal   = {Molecules},
  year      = {2023},
  volume    = {28},
  number    = {3},
  pages     = {1506},
  doi       = {10.3390/molecules28031506},
  url       = {https://doi.org/10.3390/molecules28031506}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202322
202444
202544
202644

Its field-weighted citation impact is 0.21: it has been cited 0.21 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic ductal adenocarcinoma
  • nanomedicine
  • drug resistance
  • chemoresistance
  • immunotherapy resistance
  • tumor microenvironment
  • immunosuppressive tumor microenvironment
  • tumor stroma

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Yang, X., Lu, Y., Xu, J., Du, Y., & Yu, R. (2023). Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. Molecules, 28(3), 1506. https://doi.org/10.3390/molecules28031506

How many times has this paper been cited?

14 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecules: sign in and open the PDF from this page.

Who wrote this paper?

Xiaoyan Yang, Yuan‐Fei Lu, Jianxia Xu, Yongzhong Du, Ri‐Sheng Yu.

What is the DOI of this paper?

10.3390/molecules28031506, permanently at https://doi.org/10.3390/molecules28031506. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.